Amrish Sharma
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Inflammatory Biomarkers in Disease Prognosis
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 11
- Inflammatory Biomarkers in Disease Prognosis 5
- COVID-19 and healthcare impacts 3
- Cancer Immunotherapy and Biomarkers 2
-
- Melanoma and MAPK Pathways 3
- Cell death mechanisms and regulation 2
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Steven H. Lin (6 shared papers)Shinya Neri (4 shared papers)Weiye Deng (2 shared papers)Yifan Wang (2 shared papers)Wen Jiang (2 shared papers)Nan Li (1 shared paper)Bhanu Prasad Venkatesulu (9 shared papers)Jae‐Hwan Kim (1 shared paper)
- Journals
- Cancer Research (2 papers)Scientific Reports (2 papers)Frontiers in Pharmacology (1 paper)Clinical Cancer Research (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Amrish Sharma
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Oncology 453
- Immunology 182
- Radiation 79
- Pulmonary and Respiratory Medicine 213
- Cancer Research 87
Countries citing papers authored by Amrish Sharma
This map shows the geographic impact of Amrish Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amrish Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amrish Sharma more than expected).
Fields of papers citing papers by Amrish Sharma
This network shows the impact of papers produced by Amrish Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amrish Sharma. The network helps show where Amrish Sharma may publish in the future.
Co-authors
The 25 scholars most cited alongside Amrish Sharma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 303 | |
| 2 | 2014 | 195 | |
| 3 | 2018 | 149 | |
| 4 | 2019 | 101 | |
| 5 | 2015 | 71 | |
| 6 | 2021 | 69 | |
| 7 | 2021 | 56 | |
| 8 | 2020 | 34 | |
| 9 | 2018 | 34 | |
| 10 | 2021 | 32 | |
| 11 | 2014 | 18 | |
| 12 | 2009 | 17 | |
| 13 | 2016 | 12 | |
| 14 | 2010 | 11 | |
| 15 | 2016 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2008 | 6 | |
| 20 | 2021 | 4 |
About Amrish Sharma
Amrish Sharma is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Melanoma and MAPK Pathways (3 papers), COVID-19 and healthcare impacts (3 papers), Cell death mechanisms and regulation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related gene regulation (2 papers), Epigenetics and DNA Methylation (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Oncology (453 citations), Immunology (182 citations), Radiation (79 citations), Pulmonary and Respiratory Medicine (213 citations) and Cancer Research (87 citations). Amrish Sharma has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Steven H. Lin, Shinya Neri, Weiye Deng, Yifan Wang, Wen Jiang, Nan Li, Bhanu Prasad Venkatesulu, Jae‐Hwan Kim, Chia‐Hsin Chan and Shilpa S. Dhar. Their work appears in journals such as Cancer Research, Scientific Reports, Frontiers in Pharmacology, Clinical Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.